Also found in: Medical, Wikipedia.
BCRPBanco Central de Reserva del Perú
BCRPBreast Cancer Resistance Protein
BCRPBreast Cancer Research Program
BCRPBusiness Crime Reduction Partnership (UK)
BCRPBoreal Caribou Research Program (Canada; est. 1996)
BCRPBreast Carcinoma Resistance Protein
References in periodicals archive ?
In this section, we will see how the BCRP determines its policy interest rates and what impact does this have on the banking system.
Inverted plasma membrane vesicles (so called 'inside-out' vesicles) are usually used to study the ATP-dependent ABC efflux transporters such as P-gp, BCRP and MRP-2.
Although these studies did not measure P-gp or BCRP expression, it is possible that the observed synergy results from lapatinib-mediated P-gp/BCRP inhibition, which prevents drug efflux and increases drug-induced cell death.
Determination of BCRP Activity and Evaluation of Potential BCRP-Mediated Drug-Drug Interactions in Caco-2 Cells Using the Fluorescent Substrate Pheophorbide A (Poster #T2392) Author: Ying Wang, et al.
P-gp, BCRP and MRP1), only P-gp was found to be overexpressed in SW620 Ad300 cells (Lai et al.
The BCRP says that the annualized growth rate for the country in the period January 2006 through August 2006 was 7.
The main aim of the BCRP is to prevent and deter crime from happening in the first place, rather than focusing on arrests and prosecution.
Of the three, MRP1 had the highest expression rate, at 81% across all tumor types, followed by BCRP at 66%, and PGP at 23%.
Results: P-glycoprotein- or BCRP overexpressing tumor cells did not reveal cross-resistance to reserpine.
Specific transporter proteins, BCRP is one example, have been identified by regulatory agencies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) as key mediators of unintended drug interactions*.
Caution should be exercised when ataluren is coadministered with medicinal products that are substrates or inducers of UGT1A9, inhibitors of BCRP, or substrates of OAT1, OAT3, or OATP1B3.
P-glycoprotein- overexpressing CEM/ADR5000 cells were not cross-resistant to honokiol, but MDA-MB-231 BRCP cells transfected with another ABC-transporter, BCRP, revealed 3-fold resistance.